ENZO BIOCHEM

 ENZのチャート


 ENZの企業情報

symbol ENZ
会社名 Enzo Biochem Inc. (ENZO BIOCHEM)
分野(sector)   
産業(industry)   
業種 ヘルスケア施設_サ―ビス   医療関連(Health Care)
概要 エンゾ・バイオケム(Enzo Biochem Inc.)は、製品・サービスを生産する技術力を提供することに重点を置くバイオサイエンス企業である。同社のセグメントには、Enzo Clinical Labs、Enzo Life Sciences及びEnzo Therapeuticsがある。Enzo Clinical Labsは、医師、医療センター、ほかの臨床ラボ、製薬企業に臨床サービスを提供する臨床基準研究所である。同セグメントは分子及びほかの臨床検査または検査のメニューも提供する。Enzo Life Sciencesは、臨床研究、医薬品開発、バイオサイエンス研究の顧客に製品とツールを製造、開発、販売する。Enzo Therapeuticsは、胃腸、感染、眼科及び代謝疾患の領域で複数のアプローチを開発するバイオ医薬ベンチャーである。開発パイプラインの製品には、多様な女性の健康感染症の検出、ほかの市場の病原体の同定に使用するための一連のアッセイが含まれる。  エンツォ・バイオケムは、米国の生命科学・バイオ会社。研究道具、診断法、治療法、サ―ビスに焦点を当てた秘伝や他のテストサ―ビスを医学界に提供する。事業は、臨床研究所、生命科学、治療薬に分かれる。医薬品開発と臨床研究の顧客に製品やツ―ルを開発・販売・製造のほか胃腸・感染・眼科疾患や代謝性疾患の分野でのアプロ―チを開発する。  Enzo Biochem, Inc. engages in the development, manufacture and sale of technology solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians globally. It operates through the following segments: Enzo Clinical Laboratory Services, Enzo Life Sciences Products, and Enzo Therapeutics. The Enzo Clinical Laboratory Services segment includes clinical reference laboratory providing a wide range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. The Enzo Life Sciences Products segment manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide. The Enzo Therapeutics segment develops multiple novel approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, many of which are derived from the pioneering work of Enzo Life Sciences. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.
本社所在地 527 Madison Ave New York NY 10022 USA
代表者氏名 Barry W. Weiner
代表者役職名 President Chief Financial Officer Principal Accounting Officer Treasurer Director
電話番号 +1 516-755-5500
設立年月日 27973
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 503人
url www.enzo.com
nasdaq_url
adr_tso
EBITDA (百万ドル) -14.81300
終値(lastsale)
時価総額(marketcap)
時価総額 (百万ドル) 147.39300
売上高 (百万ドル) 90.67200
企業価値(EV) (百万ドル) 109.87900
当期純利益 (百万ドル) -22.07010
決算概要 BRIEF: For the six months ended 31 January 2019 Enzo Biochem Inc. revenues decreased 23% to $40.6M. Net loss increased from $1.5M to $14.4M. Revenues reflect Clinical Labs segment decrease of 31% to $26.3M Products segment decrease of 3% to $14.3M. Higher net loss reflects Clinical Labs segment loss totaling $8M vs. income of $2.3M Products segment income decrease of 69% to $265K Other segment loss increase of 5% to $6.7M.

 ENZのテクニカル分析


 ENZのニュース

   Why Enzo Biochem Shares Are Rallying  2020/04/23 17:22:51 Benzinga
Enzo Biochem, Inc. (NYSE: ENZ ) shares were rallying Thursday following an update from the company on its comprehensive COVID-19 program. The New York-based biosciences and diagnostic company said its COVID-19 suite now includes molecular diagnostic virus screening products, detection for immunity through IgG/IgM serological ELISA products, detection of inflammation on its ELISA platform … Full story available on Benzinga.com
   Stock Alert: Enzo Biochem Shares Jump 28% In Early Trading  2020/04/23 09:16:00 RTT News
Shares of Enzo Biochem Inc. (ENZ) are rising over 28% in pre-market today, after the company announced its Comprehensive COVID-19 Program incorporating its molecular diagnostic virus screening products, detection for immunity through IgG/IgM serological ELISA products, detection of inflammation on Enzo's ELISA platform, and a promising proprietary drug candidate (SK1-I).
   SCOTUS turns away Enzo plea to revisit patent enablement  2020/03/30 21:56:10 Reuters
The U.S. Supreme Court on Monday turned away an appeal by Enzo Biochem Inc of a ruling that invalidated some of its medical testing patents, rebuffing the company's arguments that the decision contradicted precedent and contravened the standard of proof for proving patent invalidity.
   The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection  2020/03/19 11:37:15 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commencement of international shipment of rapid COVID-19 test) BioNTech SE – ADR (NASDAQ: BNTX ) Imara Inc (NASDAQ: IMRA ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 18) 89bio Inc (NASDAQ: ETNB ) AC Immune SA (NASDAQ: ACIU ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) ADMA Biologics Inc (NASDAQ: ADMA ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Agenus Inc (NASDAQ: AGEN ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Aikido Pharma Inc (NASDAQ: AIKI ) Akorn, Inc. (NASDAQ: AKRX ) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) AMAG Pharmaceuticals, Inc.
   The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index  2020/03/10 13:19:55 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Biochem, Inc. (NYSE: ENZ ) Centogene NV (NASDAQ: CNTG ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Spherix Inc (NASDAQ: SPEX ) ( added to Friday's advance on clinching an option agreement for coronavirus treatment) Down In The Dumps (Biotech stocks that hit 52-week lows March 9.) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alexion Pharmaceuticals, Inc.
   Why Enzo Biochem Shares Are Rallying  2020/04/23 17:22:51 Benzinga
Enzo Biochem, Inc. (NYSE: ENZ ) shares were rallying Thursday following an update from the company on its comprehensive COVID-19 program. The New York-based biosciences and diagnostic company said its COVID-19 suite now includes molecular diagnostic virus screening products, detection for immunity through IgG/IgM serological ELISA products, detection of inflammation on its ELISA platform … Full story available on Benzinga.com
   Stock Alert: Enzo Biochem Shares Jump 28% In Early Trading  2020/04/23 09:16:00 RTT News
Shares of Enzo Biochem Inc. (ENZ) are rising over 28% in pre-market today, after the company announced its Comprehensive COVID-19 Program incorporating its molecular diagnostic virus screening products, detection for immunity through IgG/IgM serological ELISA products, detection of inflammation on Enzo's ELISA platform, and a promising proprietary drug candidate (SK1-I).
   SCOTUS turns away Enzo plea to revisit patent enablement  2020/03/30 21:56:10 Reuters
The U.S. Supreme Court on Monday turned away an appeal by Enzo Biochem Inc of a ruling that invalidated some of its medical testing patents, rebuffing the company's arguments that the decision contradicted precedent and contravened the standard of proof for proving patent invalidity.
   The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection  2020/03/19 11:37:15 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commencement of international shipment of rapid COVID-19 test) BioNTech SE – ADR (NASDAQ: BNTX ) Imara Inc (NASDAQ: IMRA ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 18) 89bio Inc (NASDAQ: ETNB ) AC Immune SA (NASDAQ: ACIU ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) ADMA Biologics Inc (NASDAQ: ADMA ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Agenus Inc (NASDAQ: AGEN ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Aikido Pharma Inc (NASDAQ: AIKI ) Akorn, Inc. (NASDAQ: AKRX ) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) AMAG Pharmaceuticals, Inc.
   The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index  2020/03/10 13:19:55 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Biochem, Inc. (NYSE: ENZ ) Centogene NV (NASDAQ: CNTG ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Spherix Inc (NASDAQ: SPEX ) ( added to Friday's advance on clinching an option agreement for coronavirus treatment) Down In The Dumps (Biotech stocks that hit 52-week lows March 9.) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alexion Pharmaceuticals, Inc.

 関連キーワード  (ヘルスケア施設_サ―ビス 米国株 ENZO BIOCHEM ENZ )

 twitter  (公式ツイッターやCEOツイッターなど)